• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用Freelite免疫测定法进行尿游离轻链分析:多发性骨髓瘤的初步研究

Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma.

作者信息

Le Bricon Thierry, Bengoufa Djaouida, Benlakehal Mourad, Bousquet Bernard, Erlich Danielle

机构信息

Laboratoire de Biochimie A, Hôpital St-Louis AP-HP, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France.

出版信息

Clin Biochem. 2002 Oct;35(7):565-7. doi: 10.1016/s0009-9120(02)00386-7.

DOI:10.1016/s0009-9120(02)00386-7
PMID:12493586
Abstract

Evaluate the Freelite free light chain immunoassay for urine analysis in myeloma. Urine specimens from 20 patients were analyzed by Freelite (The Binding Site) and SDS-agarose gel electrophoresis (Hydragel protéinurie, Sebia). Using the kappa/lambda ratio, Freelite was more sensitive than electrophoresis to detect free light chains, but concentration was overestimated in 75% of cases. Despite high sensitivity and full automation, Freelite inaccurately measures monoclonal free light chains in urine.

摘要

评估Freelite游离轻链免疫分析在骨髓瘤尿液分析中的应用。采用Freelite(The Binding Site公司)和SDS-琼脂糖凝胶电泳(Hydragel蛋白电泳,Sebia公司)对20例患者的尿液标本进行分析。利用κ/λ比值,Freelite在检测游离轻链方面比电泳更敏感,但在75%的病例中浓度被高估。尽管具有高灵敏度和全自动性,Freelite对尿液中单克隆游离轻链的测量仍不准确。

相似文献

1
Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma.使用Freelite免疫测定法进行尿游离轻链分析:多发性骨髓瘤的初步研究
Clin Biochem. 2002 Oct;35(7):565-7. doi: 10.1016/s0009-9120(02)00386-7.
2
[Clinical significance of measurement of free light chains].[游离轻链检测的临床意义]
Rinsho Byori. 2010 Apr;58(4):401-4.
3
The FLC dimer with lambda type may false-migrate to the position of "albumin" band by urine protein electrophoresis on Sebia agarose gel-based detection system.在基于Sebia琼脂糖凝胶的检测系统上进行尿蛋白电泳时,λ型FLC二聚体可能会假迁移至“白蛋白”条带的位置。
J Clin Lab Anal. 2019 Feb;33(2):e22658. doi: 10.1002/jcla.22658. Epub 2018 Aug 27.
4
Quantification of Free Immunoglobulin Light Chains in Urine.尿液中游离免疫球蛋白轻链的定量。
J Appl Lab Med. 2023 Nov 2;8(6):1101-1114. doi: 10.1093/jalm/jfad055.
5
[Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].[多发性骨髓瘤诊断时免疫球蛋白重链/轻链对(Hevylite)与血清蛋白凝胶电泳及散射比浊检测结果的关系分析]
Cas Lek Cesk. 2015;154(6):292-302.
6
Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple Myeloma.Sebia游离轻链分析与Freelite分析在多发性骨髓瘤诊断、反应及复发评估临床管理中的比较
Clin Lymphoma Myeloma Leuk. 2019 May;19(5):e228-e237. doi: 10.1016/j.clml.2019.01.007. Epub 2019 Jan 29.
7
High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma.多发性骨髓瘤患者尿液中完整或片段化免疫球蛋白的高发生率。
Leuk Lymphoma. 2015;56(12):3348-56. doi: 10.3109/10428194.2015.1037753. Epub 2015 May 13.
8
[Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].血清游离轻链检测在单克隆丙种球蛋白病中的临床应用价值
Rinsho Ketsueki. 2010 Apr;51(4):245-52.
9
Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.两种免疫球蛋白 κ 和 λ 游离轻链检测方法的临床特异性。
Clin Chem Lab Med. 2023 Dec 5;62(5):929-938. doi: 10.1515/cclm-2023-0912. Print 2024 Apr 25.
10
Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.游离轻链浓度作为多发性骨髓瘤肿瘤标志物的临床应用价值
Ann Hematol. 2005 Sep;84(9):588-93. doi: 10.1007/s00277-005-1047-z. Epub 2005 May 10.

引用本文的文献

1
Diagnostic Advances in Multiple Myeloma.多发性骨髓瘤的诊断进展
Curr Hematol Malig Rep. 2016 Apr;11(2):111-7. doi: 10.1007/s11899-016-0314-5.
2
Screening panels for monoclonal gammopathies: time to change.单克隆丙种球蛋白病的筛查组合:是时候做出改变了。
Clin Biochem Rev. 2009 Aug;30(3):105-11.